Previous Article | Next Article 
Journal of Clinical Microbiology, May 2004, p. 2317-2320, Vol. 42, No. 5
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.5.2317-2320.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Molecular Epidemiology of the fsr Locus and of Gelatinase Production among Different Subsets of Enterococcus faecalis Isolates
Jill C. Roberts,1,2,
Kavindra V. Singh,1,3 Pablo C. Okhuysen,1,3 and Barbara E. Murray1,2,3*
Center for the Study of Emerging and Re-emerging Pathogens,1
Department of Microbiology and Molecular Genetics,2
Division of Infectious Diseases, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas 770303
Received 24 November 2003/
Returned for modification 21 January 2004/
Accepted 6 February 2004

ABSTRACT
We examined 215
Enterococcus faecalis isolates and found that
neither the two-component regulatory locus
fsr (
E. faecalis regulator) nor gelatinase production was more common in disease-associated
isolates than in isolates colonizing healthy individuals (ca.
60 to 65%). The majority of gelatinase-negative isolates, including
14 endocarditis isolates (of 80 isolates tested), contained
the previously described 23.9-kb deletion and lacked
fsrA and
fsrB. While these findings indicate that neither
fsr nor gelatinase
is required for
E. faecalis to cause infection, this study did
not address whether
fsr or gelatinase affects the severity of
disease, as it does in animal models.

TEXT
Enterococci are normally commensal flora, but they can cause
a wide range of diseases, including urinary tract infections,
bloodstream infections, wound infections, and endocarditis (
12,
13). Although there are over 20 species of enterococci (
8),
Enterococcus faecalis isolates cause the majority of infections
(
22). Despite the increasing number of cases of enterococcal
infection and the remarkable ability of these organisms to resist
antibiotics, relatively little about their pathogenesis is known
compared to what is known about some other gram-positive cocci.
Despite its role as a possible virulence factor, gelatinase is not produced by all clinical isolates, and a number of studies have attempted to correlate gelatinase activity with disease caused by E. faecalis (3, 5, 7, 17, 20, 24, 28). Nakayama et al. recently reported that a 23.9-kb chromosomal deletion involving the fsr locus was commonly found in urine isolates and was also found in most gelatinase-negative strains (17). In contrast, another study reported that fsr was present in 100% of 12 endocarditis isolates (20). In the present study, we compared clinical isolates of E. faecalis from patients with endocarditis, urinary tract infections, or blood-borne infections to fecal isolates from healthy volunteers with respect to the presence of fsr and gelatinase production.
A total of 215 E. faecalis isolates from clinical samples and from feces of healthy, community-based volunteers, collected between 1974 and 2003, were used in this study. The identification of all isolates as E. faecalis was initially done by biochemical tests and was confirmed by using an intragenic portion of the ace gene (18) as a probe for colony hybridization (data not shown). E. faecalis OG1RF (15), E. faecalis OG1SSp (6), E. faecalis V583 (23), and Enterococcus faecium TX0016 (2) are well-studied strains and were used in this study as controls. Brain heart infusion agar (Difco Laboratories, Detroit, Mich.) or brain heart infusion broth was used for growth. Gelatinase production was measured as previously described (21) after overnight incubation at 37°C and again after 7 days.
Genomic DNA was isolated as previously described (11, 29), and PCRs were performed with the Optimized Buffer B kit (Invitrogen, San Diego, Calif.) with primers listed in Table 1. The 23.9-kb deletion (17) was detected by using primer pair delsizeF1 and delsizeR1, located in open reading frame EF1841 in the V583 genome database (www.tigr.org) and in the 3' end of the partially deleted fsrC gene (Fig. 1), respectively.
Colony hybridization was performed as described (
26) with probes
labeled by using the RadPrime DNA labeling system (GIBCO/BRL,
Gaithersburg, Md.). Probes consisting of intragenic
gelE,
fsrB (
21), and
ace (
19) PCR products were generated by using OG1RF
genomic DNA templates and the primers given in Table
1, while
the
aac(6')-Ii probe (
4) (to rule out
E. faecium) was generated
by using TX16 genomic DNA (
http://www.hgsc.bcm.tmc.edu/microbial/Efaecium/).
Pulsed-field gel electrophoresis was performed as previously
described (
11,
14).
A number of investigators have studied gelatinase and E. faecalis isolates from clinical and community sources. While some of these studies measured gelatinase activity by plate assay (1, 5, 7, 10, 28), others used DNA-based techniques to determine whether the gelE gene was present (25), and such techniques are now known to not reliably predict the gelatinase phenotype. In our study, we used the gelatinase plate assay, hybridization, and PCR to correlate the observed gelatinase phenotype with the underlying fsr and gelE genotypes. Gelatinase activity was observed for 59.5% of 215 E. faecalis isolates (Table 2). With the exception of the slow-gelatinase-producing mutant OG1SSp (6), all isolates were gelatinase positive after 16 h of incubation. Previously, we reported that 27% of 30 healthy community E. faecalis fecal isolates, identified biochemically, produced gelatinase (5). However, we recently found by genetic methods that some of our original community fecal isolates were actually E. faecium isolates, leading to an underestimation of the percentage of E. faecalis isolates that were gelatinase positive. In the present study, we found that 66.6% of fecal E. faecalis isolates were gelatinase positive, compared to 58.7% of clinical isolates (endocarditis, blood, and urine isolates). Furthermore, we recently tested 15 additional fecal E. faecalis isolates from healthy volunteers and found that 87% were gelatinase producers. Gelatinase production in our clinical isolates correlates with that seen in other studies (1, 7, 16, 28).
In an earlier paper analyzing
fsr (
21), it was shown that 62%
of 95 isolates produced gelatinase but that 91% of the isolates
hybridized to a
gelE probe (very similar to the 92% found in
the present study), while 71% hybridized to an
fsrB probe; an
intact
fsr locus and
gelE are both necessary for gelatinase
production (
21). Subsequent to our observation of a discrepancy
between the presence of
gelE and gelatinase production, a study
of urine isolates obtained from a single Japanese hospital (
17)
identified a 23.9-kb deletion affecting the
fsr locus, which
explains the
gelE+,
fsrB-lacking genotype (Fig.
1). To expand
this observation, we included endocarditis, blood, and community
fecal isolates collected from geographically diverse regions
over a 29-year period. Using colony hybridization, we found
60 isolates (including 14 endocarditis isolates) that hybridized
with the
gelE probe but lacked
fsrB, suggesting that they lacked
the 23.9-kb region (Table
2). In contrast, a previous study
involving a small number of endocarditis isolates suggested
that
fsr was present in all endocarditis isolates (
20). The
discrepancy between the two studies may have resulted from the
small number of isolates used or possibly from the fact that
the probe consisted of all three
fsr genes, which may have resulted
in a positive hybridization result because 1,081 bp of the
fsrC gene is still present in strains with the deletion. While the
23.9-kb region was missing in all categories of isolates we
tested (Table
2), 16 isolates lacked both
gelE and
fsrB, similar
to the findings presented in the earlier report (
21), suggesting
an even larger deletion in these isolates, as was also reported
by Nakayama et al. (
17).
All 60 fsrB-lacking, gelE-containing isolates were confirmed by PCR to lack the 23.9-kb region. Sequencing of the 1.8-kb PCR deletion junctions from 10 isolates (4 endocarditis isolates, 2 other blood isolates, 2 urine isolates, and 2 community fecal isolates) revealed that all were identical for 300 bp on either side of the junction, indicating that the region is highly conserved and also suggesting that the deletion occurred by the same mechanism in all isolates (Fig. 1).
We also examined 35 isolates with the 23.9-kb deletion by pulsed-field gel electrophoresis. The observed banding patterns indicated at least 22 distinct strains (a difference of >7 bands) (27) among these 35 isolates from geographically diverse locations. Several urine isolates collected in the same location were related, while the majority of endocarditis, blood, and community fecal isolates were distinct strains. These results show that the deletion occurred in many distinct clinical strains, as well as in isolates from healthy volunteers.
In conclusion, the percentage of clinical isolates displaying gelatinase activity was similar to the percentage of healthy fecal isolates displaying gelatinase activity. In addition to urine isolates, the previously described 23.9-kb deleted region (17) was also lacking in endocarditis, blood, and healthy stool isolates. While fsr and gelatinase increase the severity of disease in animal models of E. faecalis infection, they are not required for the organism to cause disease (9). Controlled clinical studies will be needed to determine whether the presence of the fsr locus or gelatinase production affects the course of E. faecalis infections in humans or the outcome of the treatment.

ACKNOWLEDGMENTS
This work was supported by NIH grant AI 33516 from the Division
of Microbiology and Infectious Diseases, NIAID, to B. E. Murray
and by FDA grant FD-U-001621-01 to P. C. Okhuysen and NIH grant
RR-02558 to the Clinical Research Center.
New community fecal isolates were collected at the Clinical Research Center, University of Texas Medical School. This study was approved by the UTHSC Committee for the Protection of Human Subjects, and informed consent was obtained from participants.

FOOTNOTES
* Corresponding author. Mailing address: Center for the Study of Emerging and Re-emerging Pathogens, University of Texas Medical SchoolHouston, 6431 Fannin, 1.728 JFB, Houston, TX 77030. Phone: (713) 500-6745. Fax: (713) 500-5495. E-mail:
bem.asst{at}uth.tmc.edu.

Present address: Center for Biological Defense, University of South Florida, Tampa, FL 33612. 

REFERENCES
1 - Archimbaud, C., N. Shankar, C. Forestier, A. Baghdayan, M. S. Gilmore, F. Charbonne, and B. Joly. 2002. In vitro adhesive properties and virulence factors of Enterococcus faecalis strains. Res. Microbiol. 153:75-80.[Medline]
2 - Arduino, R. C., K. Jacques-Palaz, B. E. Murray, and R. M. Rakita. 1994. Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect. Immun. 62:5587-5594.[Abstract/Free Full Text]
3 - Blanco, A. R., S. La Terra Mule, G. Babini, S. Garbisa, V. Enea, and D. Rusciano. 2003. (-)Epigallocatechin-3-gallate inhibits gelatinase activity of some bacterial isolates from ocular infection, and limits their invasion through gelatine. Biochim. Biophys. Acta 1620:273-281.[Medline]
4 - Coque, T. M., and B. E. Murray. 1995. Identification of Enterococcus faecalis strains by DNA hybridization and pulsed-field gel electrophoresis. J. Clin. Microbiol. 33:3368-3369.[Medline]
5 - Coque, T. M., J. E. Patterson, J. M. Steckelberg, and B. E. Murray. 1995. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J. Infect. Dis. 171:1223-1229.[Medline]
6 - Dunny, G. M., R. A. Craig, R. L. Carron, and D. B. Clewell. 1979. Plasmid transfer in Streptococcus faecalis: production of multiple sex pheromones by recipients. Plasmid 2:454-465.[CrossRef][Medline]
7 - Elsner, H. A., I. Sobottka, D. Mack, M. Claussen, R. Laufs, and R. Wirth. 2000. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur. J. Clin. Microbiol. Infect. Dis. 19:39-42.[CrossRef][Medline]
8 - Facklam, R. R., M. S. Carvalho, and L. M. Teixeira. 2002. History, taxonomy, biochemical characteristics and antibiotic susceptibility testing of enterococci, p. 1-54. In M. S. Gilmore, D. B. Clewell, P. Courvalin, G. M. Dunny, B. E. Murray, and L. B. Rice (ed.), The enterococci, pathogenesis, molecular biology and antibiotic resistance. ASM Press, Washington, D.C.
9 - Jones, R. N., and L. M. Deshpande. 2003. Distribution of fsr among Enterococcus faecalis isolates from the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 41:4004-4005.[Free Full Text]
10 - Kanemitsu, K., T. Nishino, H. Kunishima, N. Okamura, H. Takemura, H. Yamamoto, and M. Kaku. 2001. Quantitative determination of gelatinase activity among enterococci. J. Microbiol. Methods 47:11-16.[CrossRef][Medline]
11 - Malathum, K., K. V. Singh, G. M. Weinstock, and B. E. Murray. 1998. Repetitive sequence-based PCR versus pulsed-field gel electrophoresis for typing of Enterococcus faecalis at the subspecies level. J. Clin. Microbiol. 36:211-215.[Abstract/Free Full Text]
12 - Moellering, R. C., Jr. 1992. Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis. 14:1173-1176.[Medline]
13 - Murray, B. E. 1990. The life and times of the enterococcus. Clin. Microbiol. Rev. 3:46-65.[Abstract/Free Full Text]
14 - Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 1990. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.[Abstract/Free Full Text]
15 - Murray, B. E., K. V. Singh, R. P. Ross, J. D. Heath, G. M. Dunny, and G. M. Weinstock. 1993. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J. Bacteriol. 175:5216-5223.[Abstract/Free Full Text]
16 - Nakayama, J., Y. Cao, T. Horii, S. Sakuda, A. D. Akkermans, W. M. de Vos, and H. Nagasawa. 2001. Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol. Microbiol. 41:145-154.[CrossRef][Medline]
17 - Nakayama, J., R. Kariyama, and H. Kumon. 2002. Description of a 23.9-kilobase chromosomal deletion containing a region encoding fsr genes which mainly determines the gelatinase-negative phenotype of clinical isolates of Enterococcus faecalis in urine. Appl. Environ. Microbiol. 68:3152-3155.[Abstract/Free Full Text]
18 - Nallapareddy, S. R., R. W. Duh, K. V. Singh, and B. E. Murray. 2002. Molecular typing of selected Enterococcus faecalis isolates: pilot study using multilocus sequence typing and pulsed-field gel electrophoresis. J. Clin. Microbiol. 40:868-876.[Abstract/Free Full Text]
19 - Nallapareddy, S. R., X. Qin, G. M. Weinstock, M. Hook, and B. E. Murray. 2000. Enterococcus faecalis adhesin, ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I. Infect. Immun. 68:5218-5224.[Abstract/Free Full Text]
20 - Pillai, S. K., G. Sakoulas, H. S. Gold, C. Wennersten, G. M. Eliopoulos, R. C. Moellering, Jr., and R. T. Inouye. 2002. Prevalence of the fsr locus in Enterococcus faecalis infections. J. Clin. Microbiol. 40:2651-2652.[Abstract/Free Full Text]
21 - Qin, X., K. V. Singh, G. M. Weinstock, and B. E. Murray. 2000. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect. Immun. 68:2579-2586.[Abstract/Free Full Text]
22 - Ruoff, K. L., L. de la Maza, M. J. Murtagh, J. D. Spargo, and M. J. Ferraro. 1990. Species identities of enterococci isolated from clinical specimens. J. Clin. Microbiol. 28:435-437.[Abstract/Free Full Text]
23 - Sahm, D. F., J. Kissinger, M. S. Gilmore, P. R. Murray, R. Mulder, J. Solliday, and B. Clarke. 1989. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1588-1591.[Abstract/Free Full Text]
24 - Schmidtchen, A., I. M. Frick, E. Andersson, H. Tapper, and L. Bjorck. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46:157-168.[CrossRef][Medline]
25 - Shepard, B. D., and M. S. Gilmore. 2002. Differential expression of virulence-related genes in Enterococcus faecalis in response to biological cues in serum and urine. Infect. Immun. 70:4344-4352.[Abstract/Free Full Text]
26 - Singh, K. V., T. M. Coque, G. M. Weinstock, and B. E. Murray. 1998. In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol. Med. Microbiol. 21:323-331.[Medline]
27 - Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
28 - Vergis, E. N., N. Shankar, J. W. Chow, M. K. Hayden, D. R. Snydman, M. J. Zervos, P. K. Linden, M. M. Wagener, and R. R. Muder. 2002. Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin. Infect. Dis. 35:570-575.[CrossRef][Medline]
29 - Wilson, K. 1994. Preparation of genomic DNA from bacteria, p. 2.4.1-2.4.2. In F. M. Ausubel, R. Brent, R. E. Kingston, D. M. David, J. G. Scidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Green Publishing Associates, Brooklyn, N.Y.
Journal of Clinical Microbiology, May 2004, p. 2317-2320, Vol. 42, No. 5
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.5.2317-2320.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Tsigrelis, C., Singh, K. V., Coutinho, T. D., Murray, B. E., Baddour, L. M.
(2007). Vancomycin-Resistant Enterococcus faecalis Endocarditis: Linezolid Failure and Strain Characterization of Virulence Factors. J. Clin. Microbiol.
45: 631-635
[Abstract]
[Full Text]
-
Arias, C. A., Cortes, L., Murray, B. E.
(2007). Chaining in enterococci revisited: correlation between chain length and gelatinase phenotype, and gelE and fsrB genes among clinical isolates of Enterococcus faecalis. J Med Microbiol
56: 286-288
[Full Text]
-
Mohamed, J. A., Murray, B. E.
(2006). Influence of the fsr locus on biofilm formation by Enterococcus faecalis lacking gelE.. J Med Microbiol
55: 1747-1750
[Full Text]
-
Lepage, E., Brinster, S., Caron, C., Ducroix-Crepy, C., Rigottier-Gois, L., Dunny, G., Hennequet-Antier, C., Serror, P.
(2006). Comparative Genomic Hybridization Analysis of Enterococcus faecalis: Identification of Genes Absent from Food Strains.. J. Bacteriol.
188: 6858-6868
[Abstract]
[Full Text]
-
Bourgogne, A., Hilsenbeck, S. G., Dunny, G. M., Murray, B. E.
(2006). Comparison of OG1RF and an Isogenic fsrB Deletion Mutant by Transcriptional Analysis: the Fsr System of Enterococcus faecalis Is More than the Activator of Gelatinase and Serine Protease.. J. Bacteriol.
188: 2875-2884
[Abstract]
[Full Text]
-
Mohamed, J. A., Murray, B. E.
(2005). Lack of Correlation of Gelatinase Production and Biofilm Formation in a Large Collection of Enterococcus faecalis Isolates. J. Clin. Microbiol.
43: 5405-5407
[Full Text]
-
Singh, K. V., Nallapareddy, S. R., Nannini, E. C., Murray, B. E.
(2005). Fsr-Independent Production of Protease(s) May Explain the Lack of Attenuation of an Enterococcus faecalis fsr Mutant Versus a gelE-sprE Mutant in Induction of Endocarditis. Infect. Immun.
73: 4888-4894
[Abstract]
[Full Text]
-
Zeng, J., Teng, F., Murray, B. E.
(2005). Gelatinase Is Important for Translocation of Enterococcus faecalis across Polarized Human Enterocyte-Like T84 Cells. Infect. Immun.
73: 1606-1612
[Abstract]
[Full Text]
-
Carniol, K., Gilmore, M. S.
(2004). Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus faecalis Biofilm Formation. J. Bacteriol.
186: 8161-8163
[Full Text]